We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-4.86%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$16B
AUM Growth
-$1.05B
Cap. Flow
-$192M
Cap. Flow %
-1.2%
Top 10 Hldgs %
35.77%
Holding
1,457
New
38
Increased
735
Reduced
275
Closed
40

Top Buys

Rank Stock Value
1
INVH icon
Invitation Homes
INVH
+$216M
2
CPT icon
Camden Property Trust
CPT
+$180M
3
AMT icon
American Tower
AMT
+$137M
4
PLD icon
Prologis
PLD
+$122M
5
EXR icon
Extra Space Storage
EXR
+$90.4M

Top Sells

Rank Stock Value
1
VTR icon
Ventas
VTR
+$181M
2
AVB icon
AvalonBay Communities
AVB
+$166M
3
HST icon
Host Hotels & Resorts
HST
+$163M
4
REG icon
Regency Centers
REG
+$134M
5
ESS icon
Essex Property Trust
ESS
+$92.2M

Sector Composition

Rank Sector Weight
1 Real Estate 60.21%
2 Technology 9.75%
3 Consumer Discretionary 4.32%
4 Healthcare 3.56%
5 Financials 3.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BPMC
1101
DELISTED
Blueprint Medicines
BPMC
$11K ﹤0.01%
172
– –
CVAC
1102
DELISTED
CureVac
CVAC
$11K ﹤0.01%
545
– –
DNLI icon
1103
Denali Therapeutics
DNLI
$3.79B
$11K ﹤0.01%
356
– –
FATE icon
1104
Fate Therapeutics
FATE
$275M
$11K ﹤0.01%
279
– –
KRTX
1105
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$11K ﹤0.01%
86
– –
ARVN icon
1106
Arvinas
ARVN
$530M
$10K ﹤0.01%
154
– –
GEN icon
1107
PUT
Gen Digital
GEN
$16.5B
$10K ﹤0.01%
2,000
-3,000
-60% -$82.5K
PCRX icon
1108
Pacira BioSciences
PCRX
$1.04B
$10K ﹤0.01%
130
– –
RY icon
1109
Royal Bank of Canada
RY
$287B
$10K ﹤0.01%
95
-55
-37% -$6.17K
VIR icon
1110
Vir Biotechnology
VIR
$1.46B
$10K ﹤0.01%
382
– –
BCRX icon
1111
BioCryst Pharmaceuticals
BCRX
$2.42B
$9K ﹤0.01%
525
– –
CYTK icon
1112
Cytokinetics
CYTK
$10.6B
$9K ﹤0.01%
245
– –
RLAY icon
1113
Relay Therapeutics
RLAY
$4B
$9K ﹤0.01%
317
– –
ZLAB icon
1114
Zai Lab
ZLAB
$2.07B
$9K ﹤0.01%
205
-1,831
-90% -$88.5K
ABCL icon
1115
AbCellera Biologics
ABCL
$1.65B
$8K ﹤0.01%
822
– –
FOLD
1116
DELISTED
Amicus Therapeutics
FOLD
$8K ﹤0.01%
813
– –
HRMY icon
1117
Harmony Biosciences
HRMY
$2.08B
$8K ﹤0.01%
171
– –
INSM icon
1118
Insmed
INSM
$22.4B
$8K ﹤0.01%
345
– –
IOVA icon
1119
Iovance Biotherapeutics
IOVA
$2.04B
$8K ﹤0.01%
458
– –
PTCT icon
1120
PTC Therapeutics
PTCT
$6.18B
$8K ﹤0.01%
206
– –
SWTX
1121
DELISTED
SpringWorks Therapeutics
SWTX
$8K ﹤0.01%
144
– –
TWST icon
1122
Twist Bioscience
TWST
$5.32B
$8K ﹤0.01%
168
+23
+16% +$1.27K
MYGN icon
1123
Myriad Genetics
MYGN
$476M
$7K ﹤0.01%
267
– –
GBT
1124
DELISTED
Global Blood Therapeutics, Inc.
GBT
$7K ﹤0.01%
214
– –
ADPT icon
1125
Adaptive Biotechnologies
ADPT
$3.61B
$6K ﹤0.01%
412
– –
43 44
45
46 47

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Daiwa Securities Group's Q1 2022 Portfolio in Review

As of Q1 2022, Daiwa Securities Group held 1,457 positions worth $16B, down 6.2% from $17B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Daiwa Securities Group's Q1 2022 filing shows 38 new, 735 increased, 275 reduced and 40 closed positions. Its largest new stake was Federal Realty Investment Trust: 21,861 shares worth $2.67M. The largest sale was Ventas, an estimated $181M.

By sector, the portfolio is most concentrated in Real Estate at 60% of assets, down from 60% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Daiwa Securities Group's largest Q1 2022 buy was Federal Realty Investment Trust: 21,861 shares worth $2.67M.
  • Daiwa Securities Group added most to Invitation Homes in Q1 2022, an estimated $216M increase.
  • Daiwa Securities Group's biggest Q1 2022 reduction was Ventas, cutting an estimated $181M.
  • Daiwa Securities Group fully exited Xilinx Inc in Q1 2022, selling an estimated $4.54M.
  • Daiwa Securities Group's ten largest holdings make up 36% of its $16B portfolio in Q1 2022.
  • Daiwa Securities Group opened 38 new positions and closed 40 in Q1 2022.
  • Daiwa Securities Group's portfolio value fell 6.2% quarter-over-quarter to $16B.

Based on Daiwa Securities Group's 13F filing for Q1 2022, filed 29 Apr 2022.